Roles and contributions of pharmacists in regulatory affairs at the Centers for Disease Control and Prevention for public health emergency preparedness and response

Journal of the American Pharmacists Association

Volumn 50, Issue 2, 2010, Pages 165-168

  Bhavsar, Tina R ^a   Kim, Hye Joo ^a   Yu, Yon ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

Bioterrorism; Centers for Disease Control and Prevention; Emergency preparedness; Influenza

Indexed keywords

ARTICLE; CIVIL DEFENSE; EMERGENCY HEALTH SERVICE; EPIDEMIC; GOVERNMENT REGULATION; HUMAN; INFLUENZA; INFLUENZA VIRUS A H1N1; LEGAL ASPECT; MANPOWER; ORGANIZATION AND MANAGEMENT; PHARMACIST; PROFESSIONAL STANDARD; PUBLIC HEALTH SERVICE; UNITED STATES; VIROLOGY;

CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); CIVIL DEFENSE; DISEASE OUTBREAKS; EMERGENCY MEDICAL SERVICES; GOVERNMENT REGULATION; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; PHARMACISTS; PROFESSIONAL ROLE; UNITED STATES;

EID: 77952539187     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2010.09220     Document Type: Article

References (3)

1. Patel A, Gorman SE. Stockpiling antiviral drugs for the next influenza pandemic. Clin Pharmacol Ther. 2009;86:241-3.
2. Parker RM, Wolf MS, Jacobson KL, Wood AJ. Risk of confusion in dosing tamiflu oral suspension in children. N Engl J Med. 2009;361:1912-3.
3. Centers for Disease Control and Prevention. Update: influenza activity-United States, April-August 2009. MMWR Morb Mortal Wkly Rep. 200918;58:1009-12.